Article: Other News To Note.

o Adventrx Pharmaceuticals Inc., of San Diego, initiated manufacturing of peptides that comprise its therapeutic vaccine for HIV, known as EradicAide, in order to prepare pharmaceutical-grade product to dose HIV-infected patients in a Phase Ib/IIa trial. The company plans to file an investigational new drug application later this year. Peptisyntha Inc., of Torrance, Calif., a wholly owned subsidiary of Solvay America Inc., will manufacture the peptides for EradicAide in its research and development and GMP-compliant manufacturing facilities.

o AlphaRx Inc., of Richmond Hill, Ontario, reported the completion of the first, commercial-size batch of Flexogan, an ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!